By

Taren Grom, Editor

By

Taren Grom, Editor

By

Taren Grom, Editor

On The Cover

Telehealth and Patient Outcomes: The Wave of the Future
Now more than ever, the industry faces the challenge of demonstrating that its products improve health outcomes and, therefore, companies need to take greater efforts to supply and support tools that help track patient outcomes and improve care. Experts participating in this forum about pharma’s role in telehealth represent several sectors of the industry: pharmaceutical, [...]

By

Robin Robinson

Features

What’s Your Social Media Strategy?
Social media has radically transformed the way customers and patients learn, act, and behave. So much so that many of our clients have come to expect it. So it is no surprise that the race is on to stake out an approach to integrate social media into the brand marketing mix. But unlike earlier transformations [...]

Social Media and Stakeholder Engagement: Moving Beyond the Patient
It is not news that social media can be leveraged for effective marketing and communications programs at the corporate and brand level alike. Social media has been around for years (more than 10, considering Wikipedia was launched in 2001), and has been deployed with success by many pharmaceutical brands. Examples include the myriad pharmaceutical corporate [...]

Digital Media and Clinical Trials: A Partnership for Delivering Speed, Cost and Quality
Effective clinical trial marketing is the backbone to trial success for many clinical trials. Finely tuned outreach programs can speed the patient recruitment process avoiding expensive clinical trial delays, and optimizing time to market of important new compounds. With more than 4,000 investigational drugs in clinical development and over 70,000 clinical research opportunities at any [...]

Driving Brand Opportunity through Social Media Advocacy
Clearly, social networks are playing an increasingly important role in the healthcare decision process. According to the Pew Research Center, a third of Internet users have read someone’s commentary about health or medical issues online, and a quarter have consulted online postings reviewing specific drugs or treatments. In addition, a quarter of social network users [...]

By

Erin Byrne, Chief Engagment Officer, Managing Partner, ghg

Feeding the Goat: Equal Parts Opportunity and Frustration
Is it just me or does anyone else have social media fatigue? It seems like we as an industry have spent the past three years talking incessantly about social media. We’ve wondered about the best platforms. We’ve stressed over a rogue post that sent our med/reg and legal departments begging for days of old. We’ve [...]

Understanding Physicians’ Social Media Presence and Behavior
Life-sciences commercial teams are always looking for new and effective ways to communicate with healthcare professionals (HCPs). Traditional personal promotion has become more restrictive as fewer physicians are allowing visits from drug and medical device reps, and non-personal promotion channels are realizing increasing use, making it harder to differentiate products. So how about social media? [...]

SHOWCASE FEATURE: Social Media: Moving Forward
According to industry statistics, millions upon millions of Americans are using social media — Facebook, Twitter, YouTube, community-based sites, Pinterest, etc. And every day the data show increasing use of social media for healthcare-related concerns. According to a recent PwC Health Research Institute (HRI) report, use of social networking sites has grown from 5% of [...]

By

Taren Grom, Editor

C-Suite: Sales Training
Sales Operations Strengthen Amid Tighter Budgeting In the midst of a changing commercial landscape, pharma sales operations leaders are striving to produce vibrant organizations that develop and reward team members. The total spend on sales analytics has declined 55% compared with 2008 levels, according to the TGaS Advisors 2012 Sales Operations Career Guide. “Leaders want [...]

By

Taren Grom, Editor

CHILE: Opportunities and Challenges
Chile is considered to be Latin America’s economic powerhouse, but it is a forgotten paradise some say because it is the most politically and economically stable country in Latin America and doesn’t generate the headlines of some of its neighbors. The Pharmaceutical Landscape Geographically anchored by the Andes and the ocean, Chile’s unique shape and [...]

By

Taren Grom, Editor

Regulatory: PDUFA V: Beyond User Fees
A new law could help provide increased communication and transparency with U.S. regulatory authorities. The Food and Drug Administration Safety and Innovation Act (FDASIA) — a new law that went into effect in October 2012 — is expected to bring overarching changes to the review of new medications. The law includes the reauthorization of the [...]

By

Denise Myshko

Direct-to-Patient Campaigns: Dos and Don’ts
As the lines ­between ­traditional DTC ­and current DTP efforts blur, ­it is more crucial than ever to know what makes a DTP campaign successful. The long-established definitions of DTC and DTP are out of date and out of touch with today’s marketing environment. In just the recent past, traditional DTC focused solely on acquisitions [...]

By

Robin Robinson

ACOs: A New Health Model for a New World
How healthcare is delivered to Medicare patients is changing as a result of the Affordable Care Act (ACA) of 2010. Accountable care organizations (ACOs) are groups of providers that aim to provide integrated and coordinated care to Medicare patients that is driven by outcomes, and, if successful, will share in any savings achieved. Healthcare delivery [...]